• Slider Image
  • Slider Image
  • Slider Image

In the Press


February 16, 2017

UCSD cancer symposium unites a coalition: Coverage of the Industry/Academia Translational Oncology Symposium and 2017 Duane Roth Memorial Award, given to Sandra Horning, M.D., chief medical officer and executive vice president of global development for the pharmaceutical giant Roche/Genentech.
   » San Diego Union Tribune article


February 14, 2017

Sandra Horning, chief medical officer and executive vice president of global development for the pharmaceutical giant Roche/Genentech, has been named the 2017 recipient of the Duane Roth Memorial Award, which will be presented February 16 at the annual Industry/Academia Translational Oncology Symposium at UC San Diego Moores Cancer Center.
   » Press Release


May 20, 2016

Researchers at UCSD Moores Cancer Center are partnering with GlaxoSmithKline, in a program called "Discovery Partnerships with Academia" or DPAc. The novel arrangement accelerates technology transfer between the drugmaker and the academic institution. Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD discusses this collaboration on page 70 of Technology Transfer Tactics.
 Technology Transfer Tactics May 2016 (PDF)


February 24, 2016

Emphasizing Collaboration at a Pivotal Moment in Cancer Research: Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD's opinion article in Xconomy San Diego features the 12th Moores Cancer Center Industry/Academic Translational Oncology Symposium on February 25 and the current cancer therapy landscape.
   » Xconomy Opinion Article


July 8, 2015

Researchers at UC San Diego School of Medicine and Moores Cancer Center are working with GSK on a bench-to-bedside project to treat leukemia and other diseases by eliminating cancer stem cells. The collaboration is part of GSK’s Discovery Partnerships with Academia (DPAc) program, where academic partners become core members of drug-hunting teams. MCC Investigator Catriona Jamieson, MD, PhD, associate professor of medicine and chief of the Division of Regenerative Medicine, will lead UC San Diego’s effort in the new DPAc team.
   » UC San Diego Health System Press Release
   » San Diego Union Tribune article


February 22, 2015

CIRM's Klein proposes $100B biomed program: Bob Klein describes his vision of how to increase biomedical funding to hasten discovery and commercialization of disease treatments. He spoke Thursday, Feb. 19, at the annual UCSD Moores Cancer Center symposium.
   » San Diego Union Tribune article


February 21, 2015

Fighting patient, fighting doctor: : Patient Theresa Blanda speaks about her experience battling cancer with the help of Moores Cancer Center Investigator Dr. Catriona Jamieson, at the 11th annual Industry/Academia Translational Oncology Symposium.
   » San Diego Union Tribune article


February 19, 2015

Katherine Connor from the San Diego Daily Transcript reports on the new funding paradigm needed for scientific research: Some of the nation’s top oncology researchers and private companies in the cancer space met at the University of California, San Diego Moores Cancer Center Thursday for the 11th annual Industry/Academic Translational Oncology Symposium.
   » San Diego Daily Transcript article


February 13, 2015

The Union-Tribune published an opinion editorial by Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD, entitled "Finding Ways to create cancer-killing swords". The op-ed features the upcoming 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium on February 19, and the ongoing collaborations at MCC.
   » Union Tribune Op-ed



» More Press



2017 Symposium: Save the Date!


The 13th Moores Cancer Center Industry/Academia Translational Oncology Symposium was held on Thursday, February 16, 2017. We thank all attendees for a successful symposium, and look forward to the collaborations being made. Learn more here.

Keynote Speaker
Duane Roth Award Lecture

Partnering for Patients in the Academy and Industry

Sandra Horning, MD

Head of Global Product Development
Chief Medical Officer
Genentech

Keynote Speaker

Finding Therapeutic Targets for Aggressive Prostate Cancer

Owen N. Witte, MD

Director, UCLA Broad Stem Cell Research Center
Distinguished Professor of Microbiology, Immunology and Molecular Genetics
University of California, Los Angeles
Investigator, Howard Hughes Medical Institute

Baseline tumoral IFNγ mRNA and PD-L1 protein expression associated with response and overall survival in durvalumab-treated NSCLC patients
Carlos Bais, PhD

Director R&D, Translational Medicine Oncology
Medimmune

Understanding and Targeting Spliceosomal Gene Mutations in Cancer
Silvia Buonamici, PhD

Director
H3 Biomedicine Inc.

Inhibition of microglial PI3Kg suppresses glioblastoma tumoigenicity by disrupting IL11-STAT3-MYC signaling.
Clark Chen, MD, PhD

Chief of Stereortactic and Radiosurgery
UC San Diego Moores Cancer Center

Targeting KRAS addicted lung cancer
David Cheresh, PhD

Distinguished Professor of Pathology
Associate Director, Innovation and Industry Alliances
UC San Diego Moores Cancer Center

Epigenetics of GBM Cancer Stem Cells
Laure Escoubet, PhD

Director, Head of Epigenetic Drug Discovery
Celgene

Combining VEGF inhibitors with strategies to manipulate the immune system in cancer
Napoleone Ferrara, MD

Senior Deputy Director for Basic Science
Distinguished Professor of Pathology
UC San Diego Moores Cancer Center

Rationale development of patient driven combinations with ibrutinib
Danelle James, MD

Head of Oncology
Pharmacyclics

RNA Processing Deregulation as Driver of Cancer Stem Cell Generation
Catriona Jamieson, MD, PhD

Associate Professor of Medicine
Chief, Division of Regenerative Medicine
Director, CIRM Alpha Stem Cell Clinic at UC San Diego
Deputy Director, Sanford Stem Cell Clinical Center
UC San Diego Moores Cancer Center

RON kinase as a Modulator of the Pancreatic Cancer Microenvironment
Andrew Lowy, MD, FACS

Chief, Division of Surgical Oncology
Professor of Surgery
UC San Diego Moores Cancer Center

Next Generation Antisense Inhibitors: Targeting difficult to drug pathways in Cancer
Robert MacLeod, PhD

Vice President Oncology Discovery
Ionis Pharmaceuticals

A Preclinical Evaluation of Niraparib Efficacy as Monotherapy, Following Platinum and Relative to Olaparib in Patient-Derived Ovarian Xenograft Tumor Models
Keith Mikule, PhD

Senior Director Discovery Pharmacology, Strategic Partnerships
TESARO

Novel cancer therapeutics from the immunomicrobiome
Jackie Papkoff, PhD

Senior Vice President & Head of Research
Evelo Biosciences

MM-141, a bispecific antibody against IGF-IR and ErbB3 designed to overcome an intrinsic resistance mechanism of IGF-IR Inhibitors
Birgit Schoeberl, PhD

Head of Discovery, SVP
Merrimack Pharmaceuticals

Translational control of normal and malignant stem cells
Rob Signer, PhD

Assistant Professor of Medicine
UC San Diego Moores Cancer Center

Targeting Hyaluronan in Pancreas Cancer
Helen Torley, MB ChB, MRCP

President and Chief Executive Officer
Halozyme, Inc.

Multivalent antibody engineering to get DR5 agonists back on TRAIL
Klaus Wagner, MD, PhD

Chief Medical Officer
Inhibrx

Junior Scientist Presentation: Pro-inflammatory pathways point the way to novel therapeutic targets for multiple myeloma

Leslie Crews, PhD

UC San Diego Moores Cancer Center
Sanford Consortium for Regenerative Medicine


Patient Advocacy Panel Discussion:
What does Real Time Translation Mean for Patients?

Moderator: Andrew Pollack

The New York Times

Panel Members:

Ezra Cohen, MD

Professor of Medicine
Associate Director, Translational Science
UC San Diego Moores Cancer Center

Tom Marsilje, PhD

Patient Advocate

Tony Reid, MD, PhD

Professor of Clinical Medicine
UC San Diego Moores Cancer Center

Stephen Schoenberger, PhD

Professor, Division of Cellular Immnology
La Jolla Institute for Allergy and Immunology,
Head of Cancer Vaccines, Human Longevity Inc.



2016 Symposium Featured Talks



Duane Roth Award


Presented by Council President Sherri Lightner, City of San Diego
Awarded to Dennis Slamon, MD, PhD, UCLA Jonsson Comprehensive Cancer Center


Keynote Presentation: Molecular diversity of human breast cancer: biologic and therapeutic implications


Dennis Slamon, MD, PhD
UCLA Jonsson Comprehensive Cancer Center


Partnering with patients to accelerate the pace of biomedical research


Corrie Painter, PhD
Broad Institute of MIT and Harvard


Detection and targeting of malignant niche mediated cancer stem cell generation


Catriona Jamieson, MD, PhD
UC San Diego Moores Cancer Center


Take a look at more featured talks.




2015 Symposium Slideshow



Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!



2014 Translational Oncology Symposium

A decade of fostering collaborations, fueling innovation & saving lives



San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.



The article is available here.

  • Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016.
         » Read Here
  • Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award.
         » Read Here
  • The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium.
         » Read Here
  • The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark.
         » Read Here
  • Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium.
         » Read Here


Our Symposium Page




9th Symposium Featured on San Diego ABC 10 News




San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.

More In the Press